INAB logo

IN8bio (INAB) Company Overview

Profile

Full Name:

IN8bio, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

July 30, 2021

Indexes:

Not included

Description:

INAB, also known as IN8bio, is a biotechnology company focused on developing innovative cell therapies for cancer treatment. They aim to harness the body’s immune system to target and destroy cancer cells, improving patient outcomes and advancing personalized medicine in oncology.

Events Calendar

Earnings

Next earnings date:

Mar 14, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Mar 14, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 12, 25 HC Wainwright & Co.
Buy
Feb 11, 25 Jones Trading
Buy
Nov 26, 24 HC Wainwright & Co.
Buy
Nov 13, 24 HC Wainwright & Co.
Buy
Aug 12, 24 Jones Trading
Hold
Jun 14, 24 Jones Trading
Buy
Jun 14, 24 HC Wainwright & Co.
Buy
Jun 4, 24 HC Wainwright & Co.
Buy
May 13, 24 HC Wainwright & Co.
Buy
Apr 10, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for IN8bio?
  • Does IN8bio pay dividends?
  • What sector is IN8bio in?
  • What industry is IN8bio in?
  • What country is IN8bio based in?
  • When did IN8bio go public?
  • Is IN8bio in the S&P 500?
  • Is IN8bio in the NASDAQ 100?
  • Is IN8bio in the Dow Jones?
  • When was IN8bio's last earnings report?
  • When does IN8bio report earnings?
  • Should I buy IN8bio stock now?

What is the ticker symbol for IN8bio?

The ticker symbol for IN8bio is NASDAQ:INAB

Does IN8bio pay dividends?

No, IN8bio does not pay dividends

What sector is IN8bio in?

IN8bio is in the Healthcare sector

What industry is IN8bio in?

IN8bio is in the Biotechnology industry

What country is IN8bio based in?

IN8bio is headquartered in United States

When did IN8bio go public?

IN8bio's initial public offering (IPO) was on July 30, 2021

Is IN8bio in the S&P 500?

No, IN8bio is not included in the S&P 500 index

Is IN8bio in the NASDAQ 100?

No, IN8bio is not included in the NASDAQ 100 index

Is IN8bio in the Dow Jones?

No, IN8bio is not included in the Dow Jones index

When was IN8bio's last earnings report?

IN8bio's most recent earnings report was on Nov 12, 2024

When does IN8bio report earnings?

The next expected earnings date for IN8bio is Mar 14, 2025

Should I buy IN8bio stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions